SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950135-99-005399
Filing Date
1999-11-24
Accepted
1999-11-24 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 GENZYME CORPORATION SC 13D/A 22106
2 DIRECTORS AND EXECUTIVE OFFICERS OF GENZYME EX-1 3210
3 STOCK PURCHASE AGREEMENT 11/12/99 EX-7 108680
4 WARRANT TO PURCHASE COMMON STOCK 11/12/99 EX-8 22824
5 WARRANT TO PURCHASE COMMON STOCK 11/22/99 EX-9 23281
  Complete submission text file 0000950135-99-005399.txt   182556
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GENZYME TRANSGENICS CORP FIVE MOUNTAIN RD FRAMINGHAM MA 01701
Business Address FIVE MOUNTAIN ROAD FRAMINGHAM MA 01701 508620-970
GENZYME TRANSGENICS CORP (Subject) CIK: 0000904973 (see all company filings)

IRS No.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: SC 13D/A | Act: 34 | File No.: 005-46637 | Film No.: 99763410
SIC: 2836 Biological Products, (No Diagnostic Substances)